These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
461 related articles for article (PubMed ID: 25519477)
1. Relationship between circulating tumor cells and tumor response in colorectal cancer patients treated with chemotherapy: a meta-analysis. Huang X; Gao P; Song Y; Sun J; Chen X; Zhao J; Liu J; Xu H; Wang Z BMC Cancer; 2014 Dec; 14():976. PubMed ID: 25519477 [TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer. Huang X; Gao P; Song Y; Sun J; Chen X; Zhao J; Xu H; Wang Z BMC Cancer; 2015 Mar; 15():202. PubMed ID: 25880692 [TBL] [Abstract][Full Text] [Related]
3. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review. Yang C; Zou K; Zheng L; Xiong B BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932 [TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cells predict survival benefit from chemotherapy in patients with lung cancer. Wu ZX; Liu Z; Jiang HL; Pan HM; Han WD Oncotarget; 2016 Oct; 7(41):67586-67596. PubMed ID: 27588489 [TBL] [Abstract][Full Text] [Related]
5. The significant prognostic value of circulating tumor cells in colorectal cancer: A systematic review and meta-analysis. Tan Y; Wu H Curr Probl Cancer; 2018; 42(1):95-106. PubMed ID: 29277243 [TBL] [Abstract][Full Text] [Related]
6. Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Rahbari NN; Aigner M; Thorlund K; Mollberg N; Motschall E; Jensen K; Diener MK; Büchler MW; Koch M; Weitz J Gastroenterology; 2010 May; 138(5):1714-26. PubMed ID: 20100481 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Circulating Tumor Cells in Ovarian Cancer: A Meta-Analysis. Zhou Y; Bian B; Yuan X; Xie G; Ma Y; Shen L PLoS One; 2015; 10(6):e0130873. PubMed ID: 26098665 [TBL] [Abstract][Full Text] [Related]
8. Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients. Wang L; Zhou S; Zhang W; Wang J; Wang M; Hu X; Liu F; Zhang Y; Jiang B; Yuan H Int J Colorectal Dis; 2019 Apr; 34(4):589-597. PubMed ID: 30627849 [TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cells and prognosis of patients with resectable colorectal liver metastases or widespread metastatic colorectal cancer: a meta-analysis. Groot Koerkamp B; Rahbari NN; Büchler MW; Koch M; Weitz J Ann Surg Oncol; 2013 Jul; 20(7):2156-65. PubMed ID: 23456317 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of the combination of circulating tumor cells plus KRAS in patients with metastatic colorectal cancer treated with chemotherapy plus bevacizumab. Sastre J; Vidaurreta M; Gómez A; Rivera F; Massutí B; López MR; Abad A; Gallen M; Benavides M; Aranda E; Rubio ED; Clin Colorectal Cancer; 2013 Dec; 12(4):280-6. PubMed ID: 24012456 [TBL] [Abstract][Full Text] [Related]
11. A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer. Barbazán J; Muinelo-Romay L; Vieito M; Candamio S; Díaz-López A; Cano A; Gómez-Tato A; Casares de Cal Mde L; Abal M; López-López R Int J Cancer; 2014 Dec; 135(11):2633-43. PubMed ID: 24752533 [TBL] [Abstract][Full Text] [Related]
12. Circulating tumor cells in newly diagnosed inflammatory breast cancer. Mego M; Giordano A; De Giorgi U; Masuda H; Hsu L; Giuliano M; Fouad TM; Dawood S; Ueno NT; Valero V; Andreopoulou E; Alvarez RH; Woodward WA; Hortobagyi GN; Cristofanilli M; Reuben JM Breast Cancer Res; 2015 Jan; 17(1):2. PubMed ID: 25572591 [TBL] [Abstract][Full Text] [Related]
13. Significant prognostic value of circulating tumor cells in esophageal cancer patients: A meta-analysis. Wang S; Du H; Li G Oncotarget; 2017 Feb; 8(9):15815-15826. PubMed ID: 28178659 [TBL] [Abstract][Full Text] [Related]
14. Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients. Thalgott M; Rack B; Eiber M; Souvatzoglou M; Heck MM; Kronester C; Andergassen U; Kehl V; Krause BJ; Gschwend JE; Retz M; Nawroth R BMC Cancer; 2015 Jun; 15():458. PubMed ID: 26051431 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis. Han L; Chen W; Zhao Q Tumour Biol; 2014 Mar; 35(3):2473-80. PubMed ID: 24218336 [TBL] [Abstract][Full Text] [Related]
16. The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature. Zhao S; Liu Y; Zhang Q; Li H; Zhang M; Ma W; Zhao W; Wang J; Yang M Breast Cancer Res Treat; 2011 Dec; 130(3):809-16. PubMed ID: 21311967 [TBL] [Abstract][Full Text] [Related]
17. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis. Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050 [TBL] [Abstract][Full Text] [Related]
18. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. Cohen SJ; Punt CJ; Iannotti N; Saidman BH; Sabbath KD; Gabrail NY; Picus J; Morse M; Mitchell E; Miller MC; Doyle GV; Tissing H; Terstappen LW; Meropol NJ J Clin Oncol; 2008 Jul; 26(19):3213-21. PubMed ID: 18591556 [TBL] [Abstract][Full Text] [Related]
19. Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy. Shen J; Zhao J; Jiang T; Li X; Zhao C; Su C; Zhou C Oncotarget; 2017 Jul; 8(30):49044-49052. PubMed ID: 28467771 [TBL] [Abstract][Full Text] [Related]
20. Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis. Jiang AM; Zheng HR; Liu N; Zhao R; Ma YY; Bai SH; Tian T; Liang X; Ruan ZP; Fu X; Yao Y Cancer Control; 2021; 28():10732748211050581. PubMed ID: 34654345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]